We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2276
DELISTED
Vital Energy
VTLE
| $663K | ﹤0.01% |
2,568
-8,702
| -77% | -$1.99M |
2016 Q2
1 quarter
|
|
2277
Upbound Group
UPBD
$1.01B
| $661K | ﹤0.01% |
52,238
-6,938
| -12% | -$86.8K |
2016 Q2
1 quarter
|
|
2278
Towne Bank
TOWN
$3.36B
| $660K | ﹤0.01% |
27,450
+21,982
| +402% | +$510K |
2016 Q2
1 quarter
|
|
2279
Cognex
CGNX
$9.19B
| $657K | ﹤0.01% |
24,850
+12,630
| +103% | +$303K |
2016 Q2
1 quarter
|
|
2280
Mercantile Bank Corp
MBWM
$1.04B
| $657K | ﹤0.01% |
24,444
-17,860
| -42% | -$463K |
2016 Q2
1 quarter
|
|
|
GRA
2281
DELISTED
W.R. Grace & Co.
GRA
| $657K | ﹤0.01% |
8,896
+1,434
| +19% | +$108K |
2016 Q2
1 quarter
|
|
2282
Paylocity
PCTY
$9.43B
| $656K | ﹤0.01% |
14,761
| – | – |
2016 Q2
1 quarter
|
|
2283
Protolabs
PRLB
$2.02B
| $656K | ﹤0.01% |
10,957
-60,495
| -85% | -$3.48M |
2016 Q2
1 quarter
|
|
2284
Axalta
AXTA
$7.5B
| $652K | ﹤0.01% |
23,051
-6,639
| -22% | -$186K |
2016 Q2
1 quarter
|
|
2285
Silvercrest Asset Management
SAMG
$83.1M
| $650K | ﹤0.01% |
54,800
| – | – |
2016 Q2
1 quarter
|
|
|
CHMT
2286
DELISTED
Chemtura Corporation
CHMT
| $646K | ﹤0.01% |
19,686
-69,442
| -78% | -$2M |
2016 Q2
1 quarter
|
|
2287
IPG Photonics
IPGP
$2.95B
| $645K | ﹤0.01% |
7,832
-11,560
| -60% | -$966K |
2016 Q2
1 quarter
|
|
|
TGH
2288
DELISTED
Textainer Group Holdings limited
TGH
| $645K | ﹤0.01% |
86,192
| – | – |
2016 Q2
1 quarter
|
|
2289
Arrowhead Research
ARWR
$8.24B
| $644K | ﹤0.01% |
87,598
+14,242
| +19% | +$92.3K |
2016 Q2
1 quarter
|
|
2290
FTAI Aviation
FTAI
$16.2B
| $644K | ﹤0.01% |
+60,312
| New | +$587K |
2016 Q3
0 quarters
|
|
|
CUNB
2291
DELISTED
CU Bancorp
CUNB
| $644K | ﹤0.01% |
28,228
+10,348
| +58% | +$249K |
2016 Q2
1 quarter
|
|
2292
Lantheus
LNTH
$6.54B
| $642K | ﹤0.01% |
+77,550
| New | +$514K |
2016 Q3
0 quarters
|
|
2293
Agios Pharmaceuticals
AGIO
$2.22B
| $640K | ﹤0.01% |
12,112
+4,501
| +59% | +$196K |
2016 Q2
1 quarter
|
|
2294
RLI Corp
RLI
$6.15B
| $639K | ﹤0.01% |
18,706
+15,932
| +574% | +$548K |
2016 Q2
1 quarter
|
|
2295
DELISTED
Emerge Energy Services LP
EMES
| $639K | ﹤0.01% |
+49,002
| New | +$559K |
2016 Q3
0 quarters
|
|
2296
ATN International
ATNI
$404M
| $636K | ﹤0.01% |
9,769
-471
| -5% | -$33.2K |
2016 Q2
1 quarter
|
|
2297
Great Southern Bancorp
GSBC
$860M
| $636K | ﹤0.01% |
15,630
-4,400
| -22% | -$177K |
2016 Q2
1 quarter
|
|
2298
Bright Horizons
BFAM
$3.45B
| $634K | ﹤0.01% |
9,482
-40,188
| -81% | -$2.71M |
2016 Q2
1 quarter
|
|
2299
FerroAtlántica
GSM
$753M
| $634K | ﹤0.01% |
+70,191
| New | +$625K |
2016 Q3
0 quarters
|
|
|
MYOK
2300
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $634K | ﹤0.01% |
+38,792
| New | +$700K |
2016 Q3
0 quarters
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.